Gordon L. Phillips

5.4k total citations · 2 hit papers
87 papers, 3.8k citations indexed

About

Gordon L. Phillips is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Gordon L. Phillips has authored 87 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hematology, 27 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Gordon L. Phillips's work include Hematopoietic Stem Cell Transplantation (27 papers), Acute Myeloid Leukemia Research (27 papers) and Lymphoma Diagnosis and Treatment (19 papers). Gordon L. Phillips is often cited by papers focused on Hematopoietic Stem Cell Transplantation (27 papers), Acute Myeloid Leukemia Research (27 papers) and Lymphoma Diagnosis and Treatment (19 papers). Gordon L. Phillips collaborates with scholars based in United States, Canada and United Kingdom. Gordon L. Phillips's co-authors include Geoffrey P. Herzig, Richard Kahn, Sue McLaughlin, Sonia Caprio, William T. Cefalu, John B. Buse, Silvio E. Inzucchi, Stefano Del Prato, M. Sue Kirkman and Francesco Rubino and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Gordon L. Phillips

85 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

How Do We Define Cure of Diabetes?

2009 753 citations Gordon L. Phillips et al. profile →
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program

1993 658 citations Nancy A. Kernan, Glenn E. Bartsch et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Gordon L. Phillips

Since Specialization

Citations

This map shows the geographic impact of Gordon L. Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon L. Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon L. Phillips more than expected).

Fields of papers citing papers by Gordon L. Phillips

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon L. Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon L. Phillips. The network helps show where Gordon L. Phillips may publish in the future.

Co-authorship network of co-authors of Gordon L. Phillips

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon L. Phillips. A scholar is included among the top collaborators of Gordon L. Phillips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon L. Phillips. Gordon L. Phillips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New cancer therapies. Are haematopoietic cell transplants a dead duck? 2020 ·Bone Marrow Transplantation ·Robert Peter Gale, Gordon L. Phillips, Hillard M. Lazarus	3
2	Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival 2018 ·Bone Marrow Transplantation ·Parameswaran Hari, Donna Reece, Jasleen K. Randhawa, Neal Flomenberg, Dianna S. Howard, (unknown), Aaron P. Rapoport, Barry Meisenberg, Joanne Filicko-O’Hara, Gordon L. Phillips, David H. Vesole	10
3	A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia 2013 ·Leukemia Research ·Dianna S. Howard, Jane L. Liesveld, Gordon L. Phillips, John Hayslip, Heidi L. Weiss, Craig T. Jordan, Mónica L. Guzmán	21
4	Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma 2012 ·Radiotherapy and Oncology ·Tithi Biswas, Eva Culakova, Jonathan W. Friedberg, Jennifer L. Kelly, Sughosh Dhakal, Jane L. Liesveld, Gordon L. Phillips, Louis S. Constine	21
5	Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS): How can we improve outcomes in the near future? 2012 ·Leukemia Research ·Gordon L. Phillips	10
6	Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation, 2011 ·Blood ·Jane L. Liesveld, Gordon L. Phillips, Michael W. Becker, Louis S. Constine, Jonathan W. Friedberg, Jeffrey R. Andolina, Laurie A. Milner, (unknown), Ollivier Hyrien, (unknown), Yuhchyau Chen	3
7	High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era 2011 ·Leukemia & lymphoma ·(unknown), Jennifer L. Kelly, Steven H. Bernstein, Jane L. Liesveld, Louis S. Constine, Michael W. Becker, Laurie A. Milner, Gordon L. Phillips, Jonathan W. Friedberg	23
8	A Phase I Trial: Dose Escalation of Melphalan in the “BEAM” Regimen Using Amifostine Cytoprotection 2010 ·Biology of Blood and Marrow Transplantation ·Gordon L. Phillips, Steven H. Bernstein, Jane L. Liesveld, Camille N. Abboud, Michael W. Becker, Louis S. Constine, (unknown), (unknown), Laurie A. Milner, David H. Vesole, Jonathan W. Friedberg	6
9	Involved Field Radiation After Autologous Stem Cell Transplant for Diffuse Large B-Cell Lymphoma in the Rituximab Era 2009 ·International Journal of Radiation OncologyBiologyPhysics ·Tithi Biswas, Sughosh Dhakal, Rui Chen, Ollivier Hyrien, Steven H. Bernstein, Jonathan W. Friedberg, Richard I. Fisher, Jane L. Liesveld, Gordon L. Phillips, Louis S. Constine	27
10	Role of Hematopoietic Stem Cell Transplantation in the Treatment of Non-Hodgkin’s Lymphoma 2008 ·Cancer treatment and research ·Philip J. Bierman, Gordon L. Phillips	3
11	Interim Analysis of the Use of the Anti-Idiotype Breast Cancer Vaccine 11D10 (TriAb®) in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer 2001 ·Clinical Breast Cancer ·Donna Reece, Kenneth A. Foon, (unknown), (unknown), E. Randolph Broun, (unknown), John F. DiPersio, H. Kent Holland, Dianna S. Howard, (unknown), (unknown), Rita K. Munn, Anastasios Raptis, Gordon L. Phillips	8
12	Delphi-Panel Analysis of Appropriateness of High-Dose Chemotherapy and Blood Cell or Bone Marrow Autotransplants in Diffuse Large-Cell Lymphoma 1998 ·Leukemia & lymphoma ·Robert Peter Gale, Rolla Edward Park, Robert W. Dubois, Philip J. Bierman, Richard I. Fisher, (unknown), B. A. Peterson, Gordon L. Phillips, Carol S. Portlock, Daniel Rosenblum, Jamés O. Armitage	6
13	Induction Failure inde novoAcute Myelogenous Leukemia is Associated with Expression of High Levels o CD34 Antigen by the Leukemic Blasts 1997 ·Leukemia & lymphoma ·Bakul I. Dalal, Vivian C. H. Wu, (unknown), Douglas E. Horsman, (unknown), Sheldon C. Naiman, John D. Shepherd, Stephen H. Nantel, Donna Reece, Heather J. Sutherland, H-G Klingemann, Gordon L. Phillips	10
14	A randomized phase II study of BB‐10010: a variant of human macrophage inflammatory protein‐1α for patients receiving high‐dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer 1997 ·British Journal of Haematology ·Steven H. Bernstein, Connie J. Eaves, Roger H. Herzig, Joseph W. Fay, Joseph P. Lynch, Gordon L. Phillips, Neal P. Christiansen, Donna Reece, Solveig G. Ericson, (unknown), (unknown), Kim Hawkins, Henrik Rasmussen, (unknown), Geoffrey P. Herzig	9
15	Is There a Place for Immunotherapy with Interleukin-2 to Prevent Relapse after Autologous Stem Cell Transplantation for Acute Leukemia? 1995 ·Leukemia & lymphoma ·Hans Klingemann, Gordon L. Phillips	13
16	Intensive conditioning regimen for bone marrow transplantation in children with high‐risk haematological malignancies 1994 ·Medical and Pediatric Oncology ·Catherine Cole, Sheila Pritchard, Paul Rogers, (unknown), Gordon L. Phillips, Ka Wah Chan	17
17	Allografting in chronic myeloid leukemia with cultured marrow: Update of the vancouver study 1993 ·Stem Cells ·Michael J. Barnett, Connie J. Eaves, Gordon L. Phillips, Donna E. Hogge, (unknown), Peter M. Lansdorp, Stephen H. Nantel, Donna Reece, John D. Shepherd, Heather J. Sutherland, Allen Eaves	6
18	Gas-chromatographic analysis of busulfan for therapeutic drug monitoring 1993 ·Cancer Chemotherapy and Pharmacology ·Leanne Embree, (unknown), (unknown), Gordon L. Phillips, Donna Reece, John J. Spinelli, (unknown), Norma J. Hudon, James H. Goldie	25
19	Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program breakdown → 1993 ·New England Journal of Medicine ·Nancy A. Kernan, Glenn E. Bartsch, Robert C. Ash, Patrick G. Beatty, Richard Champlin, Alexandra H. Filipovich, James Gajewski, John A. Hansen, Jean Henslee-Downey, Jeffrey McCullough, Philip B. McGlave, Herbert A. Perkins, Gordon L. Phillips, Jean E. Sanders, David Stroncek, E. Donnall Thomas, Karl G. Blume	658
20	Acute graft-versus-host disease of the intestine 1988 ·The American Journal of Surgery ·Gregor I. McGregor, John D. Shepherd, Gordon L. Phillips	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact